Understanding MARK Kinase and Its Role in Alzheimer's Disease
Author Information
Author(s): Timm Thomas, Marx Alexander, Panneerselvam Saravanan, Mandelkow Eckhard, Mandelkow Eva-Maria
Primary Institution: Max-Planck-Unit for Structural Molecular Biology
Hypothesis
We are searching for low molecular weight compounds to interfere with the activity of MARK and its pathways.
Conclusion
The study summarizes the structural features of MARK and its regulatory mechanisms, which may provide targets for pharmacological intervention in Alzheimer's disease.
Supporting Evidence
- MARK kinases phosphorylate tau protein, affecting its aggregation and stability.
- Phosphorylation of tau by MARK is linked to Alzheimer's disease pathology.
- Understanding MARK's structure can help in developing drugs to treat Alzheimer's.
Takeaway
MARK is a protein that helps control another protein called tau, which is important in Alzheimer's disease. By understanding how MARK works, scientists hope to find new ways to treat the disease.
Methodology
The study involves summarizing structural features and regulatory mechanisms of MARK based on existing research.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website